Cue Biopharma (CUE) Earnings Date & Reports

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CUE is expected to report earnings to fall 94.41% to -135 cents per share on November 12

Cue Biopharma CUE Stock Earnings Reports

Q3'26

Est.

$-1.35

Q2'26

Missed

by $20.54

Q1'26

Beat

by $2.22

Q4'25

Beat

by $3.00

Q3'25

Beat

by $0.02

The last earnings report on August 17 showed earnings per share of -2413 cents, missing the estimate of -359 cents. With 75.59K shares outstanding, the current market capitalization sits at 199.41M.

View a ticker or compare two or three

CUE

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CUE